Literature DB >> 6504022

Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes.

B Munch-Petersen.   

Abstract

The two thymidine kinases, TK 1 and TK 2, found in phytohemagglutinin-stimulated human lymphocytes and the thymidine kinase, TK 2N, found in unstimulated human lymphocytes were purified and characterized. All three kinases had molecular weights between 70 000 and 75 000 which increased to 170 000-200 000 in the presence of 2 mM ATP. Studies on the kinetic properties of the enzymes with thymidine and ATP as the substrates and dTTP as the inhibitor showed clear differences between TK 1 and TK 2, but a close similarity between TK 2 and TK 2N. With thymidine as the variable substrate, TK 1 showed Michaelis-Menten kinetics, whereas TK 2 and TK 2N showed characteristic biphasic kinetics. With ATP as the variable substrate, all three enzymes showed positive cooperative kinetics, but TK 2 and TK 2N lost the cooperativity in the presence of dTTP. The results from inhibition studies showed, that dTTP was a cooperative inhibitor of TK 1 but a non-cooperative inhibitor of TK 2 and TK 2N.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6504022     DOI: 10.1007/bf00224774

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  END-PRODUCT INHIBITION OF THYMIDINE KINASE ACTIVITY IN NORMAL AND LEUKEMIC HUMAN LEUKOCYTES.

Authors:  E BRESNICK; R J KARJALA
Journal:  Cancer Res       Date:  1964-06       Impact factor: 12.701

2.  Thymidine kinase, DNA synthesis and cancer.

Authors:  S Kit
Journal:  Mol Cell Biochem       Date:  1976-06-15       Impact factor: 3.396

3.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Expression of thymidine kinase variants is a function of the replicative state of cells.

Authors:  R Adler; B R McAuslan
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

5.  Persistence of thymidine kinase activity in mitochondria of a thymidine kinase-deficient derivative of mouse L cells.

Authors:  B Attardi; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

6.  Thymidine kinase in mouse liver: variations in soluble and mitochondrial-associated activity that are dependent on age, regeneration, starvation, and treatment with actinomycin D and puromycin.

Authors:  S J Adelstein; C Baldwin; H I Kohn
Journal:  Dev Biol       Date:  1971-12       Impact factor: 3.582

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Properties of partially purified thymidine kinase in adrenal tissue of hyperplasia, adenomatous hyperplasia, adenoma and carcinoma of patients with Cushing's syndrome.

Authors:  H Nawata; K Kato; H Ibayashi
Journal:  Acta Endocrinol (Copenh)       Date:  1980-02

9.  Distinctive properties of thymidine kinase isozymes induced by human and avian hepresviruses.

Authors:  S Kit; W C Leung; G N Jorgensen; D R Dubbs
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

10.  Human liver thymidine kinase. Purification and some properties of the enzyme.

Authors:  P H Ellims; M B Van der Weyden
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

View more
  7 in total

1.  Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes.

Authors:  Dario Segura-Peña; Joseph Lichter; Manuela Trani; Manfred Konrad; Arnon Lavie; Stefan Lutz
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

2.  Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

Authors:  A R Karlström; M Neumüller; J S Gronowitz; C F Källander
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

3.  X-irradiation effects on thymidine kinase (TK): II. The significance of deoxythymidine triphosphate for inhibition of TK1 activity.

Authors:  Q He; S Skog; I Welander; B Tribukait
Journal:  Cell Prolif       Date:  2002-04       Impact factor: 6.831

4.  Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.

Authors:  G Tyrsted; P C Chao; B Munch-Petersen
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

5.  Thymidine kinase isoenzymes in human acute monocytic leukemia.

Authors:  B Munch-Petersen; G Tyrsted
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

6.  Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.

Authors:  Kiran Kumar Jagarlamudi; Sara Westberg; Henrik Rönnberg; Staffan Eriksson
Journal:  BMC Vet Res       Date:  2014-10-08       Impact factor: 2.741

7.  Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.

Authors:  Sharif Hanan; Kiran Kumar Jagarlamudi; Wang Liya; He Ellen; Eriksson Staffan
Journal:  BMC Biochem       Date:  2012-06-28       Impact factor: 4.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.